Home>Topics>Companies>Bayer AG

Bayer AG

  1. All
  2. Commentary
  3. Headlines
  1. Richter expects 40-50 mln euros annual sales of Bayer patch in 3-4 yrs

    Headlines

    Tue, 27 Jan 2015

    BUDAPEST, Jan 27 (Reuters) - Hungarian drugmaker Richter expects a contraceptive patch licensed from Bayer HealthCare to produce annual revenues worth 40-50 million euros in three to four years, Chief Executive Erik Bogsch told Reuters on Tuesday.

  2. Hungary's Richter enters contraceptive patch deal with Bayer

    Headlines

    Tue, 27 Jan 2015

    BUDAPEST, Jan 27 (Reuters) - Hungarian drugmaker Richter has entered a license and distribution agreement with Bayer HealthCare to sell a transdermal contraceptive patch in Europe and some Latin American countries, Richter said on Tuesday.

  3. Salivary Gland Cancer - Pipeline Review, H2 2014

    Commentary

    Wed, 21 Jan 2015

    Companies Involved in Therapeutics Development AstraZeneca PLC Bayer AG Incuron, LLC Novartis AG Otsuka Holdings Co., Ltd. Salivary ..... AstraZeneca PLC, H2 2014 Salivary Gland Cancer - Pipeline by Bayer AG , H2 2014 Salivary Gland Cancer - Pipeline by Incuron

  4. Sanofi buys two equine health products from Bayer

    Headlines

    Wed, 17 Dec 2014

    PARIS, Dec 17 (Reuters) - Sanofi said on Wednesday that Merial, its animal health unit, had reached an agreement with Bayer HealthCare to buy two Bayer equine health products for an undisclosed amount.

  5. Bayer explores possible sale of diabetes device unit -Bloomberg

    Headlines

    Mon, 24 Nov 2014

    Nov 24 (Reuters) - Germany-based drugmaker Bayer AG is considering the sale of its diabetes device business, Bloomberg reported, citing sources.

  6. Bayer Posts Strong 3Q Led by Pharmaceuticals ; Break Off of No Moat Material Science Group on Track

    Commentary

    Thu, 30 Oct 2014

    by the drug division, Bayer reported strong third ..... expect the strong growth in pharmaceuticals sales (up 10% year over ..... growth as well. However, Bayer needs to accelerate its ..... consumer group. We believe Bayer can leverage is global

  7. From Barron’s, August 25, 2014 (Part 1)

    Commentary

    Sat, 23 Aug 2014

    emerging-markets, reduced government budgets and increased R&D costs. For those wanting to buy, Novartis [ NVS ] and Bayer [ BAYN .ge/ BAYRY ] are attractive. Pg M7, Asia: Korean steel Posco [5490.sk/ PKX ] and Chinese car maker BYD [1211

  8. Credit Market Outlook: Tight Spreads Will Keep a Lid on Returns

    Headlines

    Thu, 26 Jun 2014

    order to acquire Cadence Pharmaceuticals . While the deal gives ..... example, we only downgraded Bayer 's BAYRY "> BAYRY issuer ..... will significantly expand Bayer 's already well-positioned ..... material science toward Bayer 's health-care operations

  9. ‘Trying to Recapture the Magic’: The Strategy Behind the Pharma M&A Rush

    Headlines

    Fri, 30 May 2014

    Canada’s Valeant Pharmaceuticals wants to acquire botox maker ..... May, Germany’s Bayer clinched a $14.2 ..... billion. In India, Sun Pharmaceuticals in April bought Ranbaxy Laboratories ..... consumer division to Bayer , according to Danzon. In addition

  10. Change at the Top for IFF; Shares Still a Little Sweet

    Commentary

    Wed, 28 May 2014

    serve as chairman of the board. Andreas Fibig, a board member since 2011 and president and chairman of Bayer HealthCare Pharmaceuticals , will subsequently assume the reins. We think Fibig’s experience at several global health care firms

« Prev12345Next »
Content Partners